AGIO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Agios Pharm

NASDAQ | AGIO

26.55

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 25, 2025)

$1.54B

Market Cap

-

P/E Ratio

-7.01

EPS

$62.45

52 Week High

$22.24

52 Week Low

HEALTHCARE

Sector

AGIO Chart

Recent Chart
Price Action

AGIO Technicals

Tags:

AGIO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $32M
Total Revenue $36M
Cost Of Revenue $4.2M
Costof Goods And Services Sold $4.2M
Operating Income -$426M
Selling General And Administrative $157M
Research And Development $301M
Operating Expenses $458M
Investment Income Net -
Net Interest Income $48M
Interest Income $48M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.7M
Income Before Tax $718M
Income Tax Expense $44M
Interest And Debt Expense -
Net Income From Continuing Operations $674M
Comprehensive Income Net Of Tax -
Ebit -$426M
Ebitda -$420M
Net Income $674M

Revenue & Profitability

Earnings Performance

AGIO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.7B
Total Current Assets $966M
Cash And Cash Equivalents At Carrying Value $76M
Cash And Short Term Investments $76M
Inventory $28M
Current Net Receivables $4.1M
Total Non Current Assets $698M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $638M
Short Term Investments $817M
Other Current Assets $40M
Other Non Current Assets -
Total Liabilities $122M
Total Current Liabilities $81M
Current Accounts Payable $17M
Deferred Revenue -
Current Debt -
Short Term Debt $17M
Total Non Current Liabilities $41M
Capital Lease Obligations $57M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $57M
Other Current Liabilities $47M
Other Non Current Liabilities $880K
Total Shareholder Equity $1.5B
Treasury Stock -
Retained Earnings -$149M
Common Stock $73K
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$390M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.7M
Capital Expenditures $1.7M
Change In Receivables -
Change In Inventory -$8.5M
Profit Loss -
Cashflow From Investment $363M
Cashflow From Financing $14M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $674M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $32M
Total Revenue $36M
Cost Of Revenue $4.2M
Costof Goods And Services Sold $4.2M
Operating Income -$426M
Selling General And Administrative $157M
Research And Development $301M
Operating Expenses $458M
Investment Income Net -
Net Interest Income $48M
Interest Income $48M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.7M
Income Before Tax $718M
Income Tax Expense $44M
Interest And Debt Expense -
Net Income From Continuing Operations $674M
Comprehensive Income Net Of Tax -
Ebit -$426M
Ebitda -$420M
Net Income $674M

AGIO News

AGIO Profile

Agios Pharm Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Agios Pharmaceuticals, Inc. is a prominent biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing transformative therapies targeting diseases related to cellular metabolism. With a strong focus on oncology and rare genetic disorders, Agios utilizes its extensive knowledge of metabolic pathways to create innovative treatments that exemplify precision medicine. The company boasts a promising pipeline and actively engages in strategic collaborations to enhance research and development efforts, demonstrating its commitment to advancing scientific understanding and significantly improving patient outcomes through state-of-the-art therapeutic solutions.

LPTX
+368.57%
$2.05
INHD
-33.64%
$0.48
ENLV
+13.73%
$1.02
VHAI
0.00%
$0.00
IVP
+22.52%
$0.19
NVDA
-5.94%
$171.70
CETY
+94.85%
$2.08
TWOH
-13.33%
$0.00
ASST
+10.78%
$1.13
KVUE
+0.72%
$16.76
AXDX
-61.36%
$0.03
PFE
+0.71%
$25.22
OSCR
+22.32%
$16.49
GOOG
+6.28%
$318.47
MARA
+11.32%
$11.21
NBIS
+10.37%
$91.90
ADAP
-15.14%
$0.05
BITF
+14.81%
$2.79
CJET
-33.15%
$1.27
BTBT
+9.56%
$2.29
CIFR
+18.09%
$16.71
RGTI
+12.63%
$26.57
SOND
-23.45%
$0.12
CHR
-15.80%
$0.04
IONQ
+12.10%
$46.76
RMBL
+60.50%
$3.21
NIO
-4.00%
$5.52
LNW
-3.71%
$86.22
CMND
-9.37%
$0.17
ADD
-25.47%
$0.05
LNAI
+15.74%
$1.47
SRM
+53.27%
$10.30
ACHR
+3.62%
$7.44
HOOD
+7.14%
$114.97
RELI
+0.20%
$0.72
VNRX
-7.40%
$0.30
WLGS
-5.57%
$0.04
MRK
+2.70%
$100.40
MTSR
-0.35%
$70.50
BMNU
+39.92%
$7.36
FLEX
+3.00%
$56.95
BMY
+3.26%
$47.76
AEHL
+21.34%
$3.07
BURU
+3.03%
$0.21
VINE
+21.15%
$0.30
VSA
-27.13%
$0.13
RUBI
+6.48%
$0.15
AFMD
-34.94%
$0.18
AMD
-9.11%
$195.44
AUTL
+17.33%
$1.45
HIMS
+8.84%
$37.78
GOOGL
+1.62%
$323.76
CLF
+6.60%
$11.94
KDP
-1.36%
$27.36
GRYP
-10.38%
$1.38
NVVE
-6.17%
$0.24
MODV
-25.22%
$0.43
ONDS
-2.46%
$8.50
BSX
+1.19%
$98.04
LAES
+10.07%
$4.15
BMRN
+1.48%
$55.50
QS
+3.13%
$11.83
AZI
+6.13%
$0.07
BFLY
+23.77%
$3.28
EXC
+1.04%
$46.23
JBS
+4.15%
$14.30
INSM
+4.11%
$206.93
ET
-0.12%
$16.49
HL
+8.09%
$14.46
YGMZ
-84.87%
$0.16
AMC
0.00%
$2.20
DKNG
-1.83%
$29.44
SAND
-6.04%
$12.12
IREN
-7.40%
$44.90
FUBO
-1.89%
$3.10
AUR
+3.17%
$3.90
SHOT
-74.37%
$0.39
PG
-2.61%
$146.98
PM
-2.69%
$151.06
ZAPP
-46.30%
$0.15
TSM
+3.48%
$284.64
PSKY
-5.22%
$15.06
AAPL
+0.95%
$278.56
NGD
+7.40%
$7.25
KDLY
+0.24%
$0.44
BMNR
-3.40%
$30.04
AAL
+4.08%
$13.63
RVTY
+2.35%
$100.58
ON
+1.47%
$47.39
ERIC
0.00%
$9.40
GLW
+3.95%
$82.60
MCHP
+1.58%
$51.25
MIMI
+25.84%
$0.55
RBLX
+1.49%
$90.58
PRMB
-0.59%
$14.96
RF
-0.24%
$24.85
TSLA
-2.03%
$409.28
SATS
+3.33%
$70.92
MDLZ
-1.42%
$56.19
PLTR
-2.68%
$157.88
LPTX
+368.57%
$2.05
INHD
-33.64%
$0.48
ENLV
+13.73%
$1.02
VHAI
0.00%
$0.00
IVP
+22.52%
$0.19
NVDA
-5.94%
$171.70
CETY
+94.85%
$2.08
TWOH
-13.33%
$0.00
ASST
+10.78%
$1.13
KVUE
+0.72%
$16.76
AXDX
-61.36%
$0.03
PFE
+0.71%
$25.22
OSCR
+22.32%
$16.49
GOOG
+6.28%
$318.47
MARA
+11.32%
$11.21
NBIS
+10.37%
$91.90
ADAP
-15.14%
$0.05
BITF
+14.81%
$2.79
CJET
-33.15%
$1.27
BTBT
+9.56%
$2.29
CIFR
+18.09%
$16.71
RGTI
+12.63%
$26.57
SOND
-23.45%
$0.12
CHR
-15.80%
$0.04
IONQ
+12.10%
$46.76
RMBL
+60.50%
$3.21
NIO
-4.00%
$5.52
LNW
-3.71%
$86.22
CMND
-9.37%
$0.17
ADD
-25.47%
$0.05
LNAI
+15.74%
$1.47
SRM
+53.27%
$10.30
ACHR
+3.62%
$7.44
HOOD
+7.14%
$114.97
RELI
+0.20%
$0.72
VNRX
-7.40%
$0.30
WLGS
-5.57%
$0.04
MRK
+2.70%
$100.40
MTSR
-0.35%
$70.50
BMNU
+39.92%
$7.36
FLEX
+3.00%
$56.95
BMY
+3.26%
$47.76
AEHL
+21.34%
$3.07
BURU
+3.03%
$0.21
VINE
+21.15%
$0.30
VSA
-27.13%
$0.13
RUBI
+6.48%
$0.15
AFMD
-34.94%
$0.18
AMD
-9.11%
$195.44
AUTL
+17.33%
$1.45
HIMS
+8.84%
$37.78
GOOGL
+1.62%
$323.76
CLF
+6.60%
$11.94
KDP
-1.36%
$27.36
GRYP
-10.38%
$1.38
NVVE
-6.17%
$0.24
MODV
-25.22%
$0.43
ONDS
-2.46%
$8.50
BSX
+1.19%
$98.04
LAES
+10.07%
$4.15
BMRN
+1.48%
$55.50
QS
+3.13%
$11.83
AZI
+6.13%
$0.07
BFLY
+23.77%
$3.28
EXC
+1.04%
$46.23
JBS
+4.15%
$14.30
INSM
+4.11%
$206.93
ET
-0.12%
$16.49
HL
+8.09%
$14.46
YGMZ
-84.87%
$0.16
AMC
0.00%
$2.20
DKNG
-1.83%
$29.44
SAND
-6.04%
$12.12
IREN
-7.40%
$44.90
FUBO
-1.89%
$3.10
AUR
+3.17%
$3.90
SHOT
-74.37%
$0.39
PG
-2.61%
$146.98
PM
-2.69%
$151.06
ZAPP
-46.30%
$0.15
TSM
+3.48%
$284.64
PSKY
-5.22%
$15.06
AAPL
+0.95%
$278.56
NGD
+7.40%
$7.25
KDLY
+0.24%
$0.44
BMNR
-3.40%
$30.04
AAL
+4.08%
$13.63
RVTY
+2.35%
$100.58
ON
+1.47%
$47.39
ERIC
0.00%
$9.40
GLW
+3.95%
$82.60
MCHP
+1.58%
$51.25
MIMI
+25.84%
$0.55
RBLX
+1.49%
$90.58
PRMB
-0.59%
$14.96
RF
-0.24%
$24.85
TSLA
-2.03%
$409.28
SATS
+3.33%
$70.92
MDLZ
-1.42%
$56.19
PLTR
-2.68%
$157.88
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.